Cellosaurus SpESFX (CVCL_WS49)
Cell line name | SpESFX | ||
---|---|---|---|
Synonyms | SpESF-X | ||
Accession | CVCL_WS49 | ||
Resource Identification Initiative | To cite this cell line use: SpESFX (RRID:CVCL_WS49) | ||
Comments | Group: Hybridoma fusion partner cell line. Group: Patented cell line. Group: Serum/protein free medium cell line. Characteristics: Transfected with a hBCL2-EEE-pZeoSV2+ construct. Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine. Genetic integration: Method=Transfection/transduction; Gene=HGNC; 990; BCL2 (Note=With p.Thr69Glu, p.Ser70Glu and p.Ser87Glu = BCL2-EEE). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P17493; Streptoalloteichus hindustanus ble (BleoR). | ||
Disease | Mouse plasma cell myeloma (NCIt: C125417) | ||
Species of origin | Mus musculus (Mouse) (NCBI Taxonomy: 10090) | ||
Hierarchy | Parent: CVCL_WS48 (SpESF) Children:
| ||
Sex of cell | Female | ||
Category | Cancer cell line | ||
Publications | Patent=US7608425 PubMed=21473000; DOI=10.1002/btpr.584 | ||
Cross-references | |||
Encyclopedic resources | Wikidata; Q98132815 | ||
Entry history | |||
Entry creation | 05-Jul-2019 | ||
Last entry update | 10-Sep-2024 | ||
Version number | 5 |